Navigation Links
Particle Sciences Expands Biopharmaceutical Development Infrastructure
Date:7/15/2014

BETHLEHEM, Pa., July 15, 2014 /PRNewswire/ -- Particle Sciences, Inc. has expanded its development capabilities to accommodate the increasing demand for biopharmaceutical formulation and analysis.  According to Robert Becker, Vice President Biopharmaceutical Sales and Business Development at Particle Sciences, "Our company has been working with biologics for some time, accumulating significant infrastructure and intellectual property.  We regularly work with biopharmaceuticals and vaccines ranging from therapeutic proteins, including monoclonal antibodies, to nucleotides, to vaccine antigens and immunomodulators.  Adding cell culture and extensive instrumentation to support the testing and characterizations of these biopharmaceuticals was planned for later this year but we've accelerated implementation to meet our client's needs."   With this most recent expansion, Particle Sciences can now run the full gambit of testing including, among others, ELISA, SDS-PAGE, Western blots, image analysis, HPLC, HPLC-MS, ligand-receptor binding assays, cellular proliferation, cytotoxicity and cellular activation assays.   

Mark Mitchnick, Particle Sciences' CEO added, "This expansion augments our existing formulation and sterile manufacturing offerings.  With our unique approach to biopharmaceutical formulation and the ability to quickly take our clients into the clinic, Particle Sciences anticipates becoming a leader in large molecule formulation and clinical trial supply."  The company sees a rapidly growing industrial need for these services as biopharmaceutical and biosimilar products become an increasingly important component to the health care products market. Particle Sciences' formulation portfolio enables the broader, more efficient development and application of biopharmaceuticals, and can differentiate products in the biosimilars field.

Particle Sciences is an integrated provider of drug development services.  Particle Sciences focuses on BCS II/III/IV molecules, biologics and highly potent compounds through a variety of technologies including emulsions, gels, micro and nano-particulates, drug/device combination products, solid solutions and others. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic.  We also have an extensive history in government contracting alongside our clients.  The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania.  Visit www.particlesciences.com,  email info@particlesciences.com or contact us at (610) 861- 4701 for information.

Contact: Maureen Grieco
Maureen.grieco@particlesciences.com


'/>"/>
SOURCE Particle Sciences
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Shimadzu Introduces New Particle Size Analyzer for Measurement of Nanoparticles in Life Sciences and R&D
2. New magnetic behavior in nanoparticles could lead to even smaller digital memories
3. DNA motor walks along nanotube, transports tiny particle
4. Nanoparticles and their orbital positions
5. Researchers split water into hydrogen, oxygen using light, nanoparticles
6. IceCube Particle Detector in Antarctica Records High-energy Neutrinos
7. Scientists develop way to successfully give nanoparticle therapeutics orally
8. Pills of the future: Nanoparticles
9. Ultra-sensitive force sensing with a levitating nanoparticle
10. Magnetic nanoparticles could aid heat dissipation
11. BHR Pharma Engages Particle Sciences to Develop Nasal Progesterone for Traumatic Brain Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2017)... ... September 14, 2017 , ... Boston Strategic Partners, ... with Health Economics and Outcomes Research (HEOR) and ‘big data’ to provide in-depth ... US healthcare spending exceeded $3.0 trillion with nearly 1/3 spent on hospitalizations. BSP ...
(Date:9/14/2017)... ... September 14, 2017 , ... ... exploratory analytics solutions, today announced that its Anzo Smart Data Lake has been ... list includes technologies and solutions that help organizations succeed in surpassing their knowledge ...
(Date:9/12/2017)... NJ (PRWEB) , ... September 12, 2017 , ... ... of the fastest growing b2b product testing and development companies will be exhibiting ... service offerings. , Contract Pharma is an educational conference ...
(Date:9/12/2017)... Pittsburgh, PA (PRWEB) , ... September 12, 2017 ... ... Program Committee is extremely pleased to announce that Jeremy Nicholson, Head of the ... Faculty of Medicine, will deliver the 2018 Wallace H. Coulter Lecture. His ...
Breaking Biology Technology:
(Date:5/16/2017)... TEANECK, N.J. , May 16, 2017  Veratad ... leading provider of online age and identity verification solutions, ... the K(NO)W Identity Conference 2017, May 15 thru May ... Ronald Regan Building and International Trade Center. ... across the globe and in today,s quickly evolving digital ...
(Date:4/24/2017)... Janice Kephart , former 9/11 ... Partners, LLP (IdSP) , today issues the following ... March 6, 2017 Executive Order: Protecting the ... be instilled with greater confidence, enabling the reactivation ... applications are suspended by until at least July ...
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... Report on Form 10-K on Thursday April 13, 2017 with the ... The ... section of the Company,s website at http://www.nxt-id.com  under "SEC Filings," ... 2016 Year Highlights: Acquisition of ...
Breaking Biology News(10 mins):